Galloway Jones Consulting
Galloway Jones Consulting Ltd was founded in 2007 by Alan Jones. Alan is able to offer more than ten years’ experience recruiting for the Pharmaceutical Industry in both the UK and Europe. This knowledge allows him to create a bespoke recruitment service for client and candidate alike. GJC recruit in all areas of the Pharmaceutical industry; including, but not limited to: Public Relations, Medical Communications, Medical Writing, Marketing, Market Research, Health Economics, Sales and Business Development and Medical Affairs.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…
Company Details
Latest Content from PMHub
The value medical communications bring to phase 2/3 of drug development
Press Releases | October 17, 2022 | Resonant Group
Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond...
From insight to action in Medical Affairs
Press Releases | October 17, 2022 | Medscape Medical Affairs
Christina Hoffmann, Global Head, of Medscape Medical Affairs at WebMD is one of many industry experts in this article discussing how physicians’ increasingly digital-first consumption of disease-state education offers pharma...
Beyond Knowledge Transfer: Generating Actionable Insights for Medical Affairs
Videos and Podcasts | October 14, 2022 | Medscape Medical Affairs
Presented at Evidence Life Science’s Medical Affairs Digital Conference March 9, 2021. Presenters: Christina L. Hoffman, MS, Global Lead for Medscape Medical Affairs Gökhan Tanju, Executive Director, Business Intelligence for...
Actionable Insights for Medical Affairs Teams: Lessons from the Front Lines
Videos and Podcasts | October 14, 2022 | Medscape Medical Affairs
Presented at Fierce Pharma’s Medical Affairs Launch Excellence Conference February 4, 2021. With Christina L. Hoffman, MS, Global Lead for Medscape Medical Affairs. Chris speaks to two primary remits: Knowledge...
Patient Centric Approaches for Rare and Ultra-Rare Diseases
Videos and Podcasts | October 13, 2022 | Impetus Digital
Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi, shares how Chiesi is revolutionizing the lives of people living with rare diseases on a global scale....
Bedrock expands growing strategy and scientific teams
Press Releases | October 13, 2022 | Resonant Group
Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.
Genesis Research Insights & Evidence webinar 20 Oct: Reserve your place!
Press Releases | October 13, 2022 | Genesis Research Group
Join Priti Jhingran of Genesis Research and Tijana Ignjatovic of Market Access Transformation (MAT) for their webinar 'Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to...
WRG Launches Attendee Experience Design (AXD) Unit
Press Releases | October 13, 2022 | The Creative Engagement Group
WRG, the events and experiential division of The Creative Engagement Group, launches Attendee Experience Design (AXD) Unit. Combining Behavioural Science, Data Insights, and Digital and Live UX in One Unit
#Wellbeing Week: Let’s tackle pressure
White Papers and Resources | October 13, 2022 | Fox&Cat
Hear from Paul Hutchings, founder of foxandcat.online, with tips and advice to help your comms team thrive under pressure
The promised land of gene therapy: Commercialization of novel gene-editing technology in beta-thalassemia
White Papers and Resources | October 12, 2022 | Avalere Health
With transformative treatments that leverage CRISPR technology, there are many challenges to overcome throughout the journey of development through to patient access. We interviewed a researcher at a top 20...